Shalita AR - Search Results

1

Effects of tazarotene 0.1 % cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials.

Shalita AR, Berson DS, Thiboutot DM, Leyden JJ, Parizadeh D, Sefton J, Walker PS, Gibson JR; Tazarotene Cream in Acne Clinical Study Investigator Group. Shalita AR, et al. Clin Ther. 2004 Nov;26(11):1865-73. doi: 10.1016/j.clinthera.2004.11.012. Clin Ther. 2004. PMID: 15639698

2

Topical retinoids in inflammatory acne: a retrospective, investigator-blinded, vehicle-controlled, photographic assessment.

Leyden JJ, Shalita A, Thiboutot D, Washenik K, Webster G. Leyden JJ, et al. Clin Ther. 2005 Feb;27(2):216-24. doi: 10.1016/j.clinthera.2005.02.009. Clin Ther. 2005. PMID: 15811485

3

Tazarotene gel is safe and effective in the treatment of acne vulgaris: a multicenter, double-blind, vehicle-controlled study.

Shalita AR, Chalker DK, Griffith RF, Herbert AA, Hickman JG, Maloney JM, Miller BH, Tschen EH, Chandraratna RA, Gibson JR, Lew-Kaya DA, Lue JC, Sefton J. Shalita AR, et al. Cutis. 1999 Jun;63(6):349-54. Cutis. 1999. PMID: 10388959 Clinical Trial.

4

Current concepts in the treatment of acne: report from a clinical roundtable.

Berson DS, Chalker DK, Harper JC, Leyden JJ, Shalita AR, Webster GF. Berson DS, et al. Among authors: shalita ar. Cutis. 2003 Jul;72(1 Suppl):5-13. Cutis. 2003. PMID: 12887172 Review.

5

Combination therapy with adapalene gel 0.1% and doxycycline for severe acne vulgaris: a multicenter, investigator-blind, randomized, controlled study.

Thiboutot DM, Shalita AR, Yamauchi PS, Dawson C, Arsonnaud S, Kang S; Differin Study Group. Thiboutot DM, et al. Among authors: shalita ar. Skinmed. 2005 May-Jun;4(3):138-46. doi: 10.1111/j.1540-9740.2005.04279.x. Skinmed. 2005. PMID: 15891249 Free article. Clinical Trial.

6

Adapalene gel, 0.1%, as maintenance therapy for acne vulgaris: a randomized, controlled, investigator-blind follow-up of a recent combination study.

Thiboutot DM, Shalita AR, Yamauchi PS, Dawson C, Kerrouche N, Arsonnaud S, Kang S. Thiboutot DM, et al. Among authors: shalita ar. Arch Dermatol. 2006 May;142(5):597-602. doi: 10.1001/archderm.142.5.597. Arch Dermatol. 2006. PMID: 16702497 Clinical Trial.

7

Comparison of tazarotene and minocycline maintenance therapies in acne vulgaris: a multicenter, double-blind, randomized, parallel-group study.

Leyden J, Thiboutot DM, Shalita AR, Webster G, Washenik K, Strober BE, Shupack J. Leyden J, et al. Among authors: shalita ar. Arch Dermatol. 2006 May;142(5):605-12. doi: 10.1001/archderm.142.5.605. Arch Dermatol. 2006. PMID: 16702498 Clinical Trial.

8

Changing the face of acne therapy.

Ghali F, Kang S, Leyden J, Shalita AR, Thiboutot DM. Ghali F, et al. Among authors: shalita ar. Cutis. 2009 Feb;83(2 Suppl):4-15. Cutis. 2009. PMID: 19363873 Review.

9

Mechanism-based selection of pharmacologic agents for rosacea.

Shalita A, Leyden J. Shalita A, et al. Cutis. 2004 Jan;73(1 Suppl):15-8. Cutis. 2004. PMID: 14959941 Review.

10

Antibiotic stewardship in dermatology: limiting antibiotic use in acne.

Dreno B, Thiboutot D, Gollnick H, Bettoli V, Kang S, Leyden JJ, Shalita A, Torres V; Global Alliance to Improve Outcomes in Acne. Dreno B, et al. Eur J Dermatol. 2014 May-Jun;24(3):330-4. doi: 10.1684/ejd.2014.2309. Eur J Dermatol. 2014. PMID: 24721547 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

125 results

Search Page